Exercise-Induced Lactate and Cognitive Function (ExLBC)
The Effect of Exercise-Induced Lactate on BDNF and Cognition
1 other identifier
interventional
32
1 country
1
Brief Summary
A single bout of exercise can rapidly improve cognitive functions including memory, attention, and executive functions, which help us navigate through everyday life. However, we do not fully understand the mechanism behind this process. A promising candidate mechanism is lactate, which was previously considered merely a waste product of our muscles during exercise. It is now recognized as an important molecule that is used by the brain as an energy source. Studies have shown that increases in lactate during exercise are positively related to improved cognitive function after completion of exercise. Another potential mechanism involves the increase in neurotrophins such as brain-derived neurotrophic factor (BDNF) following exercise. The increase in lactate and BDNF during exercise may be connected to cause these cognitive improvements. However, because lactate increases with higher exercise intensities, we currently do not know how lactate specifically impacts brain health. To address this, muscle and blood lactate concentrations can be experimentally manipulated during exercise using sodium bicarbonate (NaHCO3) supplementation and will allow us to explore how lactate specifically affects brain function. The purpose of this project is to investigate the effect of exercise-induced lactate on BDNF and cognition following oral NaHCO3 supplementation in young adults. We hypothesize that BDNF levels will be higher, and cognition will be improved in executive function, visuospatial memory, and working memory in the NaHCO3 condition due to higher plasma lactate during exercise compared to placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2025
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedStudy Start
First participant enrolled
February 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2025
CompletedFebruary 10, 2025
August 1, 2024
6 months
February 4, 2025
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognitive Function (Executive Function)
The Stroop Task will be used to measure executive function (selective attention and inhibitory control).
3-hour
Secondary Outcomes (6)
Cognitive Function (Working Memory)
3-hour
Cognitive Function (Visuospatial Memory)
3-hour
Blood Lactate
3-hour
Sodium Bicarbonate (NaHCO3)
3-hour
Blood pH
3-hour
- +1 more secondary outcomes
Study Arms (2)
Placebo
PLACEBO COMPARATORSingle dose of a placebo supplement (0.4 g/kg body weight of sodium chloride gelatin capsules).
Sodium bicarbonate (NaHCO3)
EXPERIMENTALSingle dose of sodium bicarbonate supplement (0.4 g/kg body weight of NaHCO3 gelatin capsules).
Interventions
Ingestion of gelatin capsules containing 0.4 g/kg body weight of sodium bicarbonate (NaHCO3) followed by 90 minutes of rest. Continuous high intensity cycling to be performed following 90-minute resting measures.
Ingestion of gelatin capsules containing 0.4 g/kg body weight of sodium chloride (NaCl) followed by 90 minutes of rest. Continuous high intensity cycling to be performed following 90-minute resting measures.
Eligibility Criteria
You may qualify if:
- Between the ages of 18-35 years old.
- Perform ≥150 minutes of moderate-to-vigorous aerobic activity per week.
You may not qualify if:
- Diagnosis of Type 2 Diabetes.
- Presence of hypoglycaemia.
- History of concussion(s) with persistent symptoms.
- History of mental health conditions.
- History of cardiovascular events requiring hospitalization (e.g., heart attack).
- Pre-existing injuries that prevent completion of aerobic exercise.
- Presence of colour-blindness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McMaster University
Hamilton, Ontario, L8S 4K1, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeremy J Walsh, PhD
McMaster University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 4, 2025
First Posted
February 10, 2025
Study Start
February 10, 2025
Primary Completion
July 30, 2025
Study Completion
September 20, 2025
Last Updated
February 10, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 12 months and ending 36 months following article publication.
- Access Criteria
- Anyone who wishes to access the data.
The investigators will share individual patient data (de-identified) with researchers upon request.